The epidemiology of nonalcoholic steatohepatitis

Por Younossi, Zobair M.
Publicado no Clin Liver Dis (Hoboken) (2018)

The price of shortening anti–hepatitis C virus therapy: Is this truly cost saving?

Por Younossi, Zobair M.
Publicado no Clin Liver Dis (Hoboken) (2015)

Treatment options for nonalcoholic fatty liver disease

Por Lam, Brian, Younossi, Zobair M.
Publicado em 2010

Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease

Por Mishra, Alita, Younossi, Zobair M
Publicado em 2012

Identifying patients at risk from nonalcoholic fatty liver-related hepatocellular carcinomas

Por Sayiner, Mehmet, Younossi, Zobair M
Publicado no Hepat Oncol (2016)

Natural history of nonalcoholic fatty liver disease

Por Mehta, Rohini, Younossi, Zobair M.
Publicado no Clin Liver Dis (Hoboken) (2012)

Pediatric Non-Alcoholic Fatty Liver Disease

Por Bush, Haley, Golabi, Pegah, Younossi, Zobair M.
Publicado no Children (Basel) (2017)

Non-Invasive markers for hepatic fibrosis

Por Baranova, Ancha, Lal, Priyanka, Birerdinc, Aybike, Younossi , Zobair M
Publicado em 2011

Exercise as an intervention for patients with end-stage liver disease: Systematic review

Por Locklear, Cameron T., Golabi, Pegah, Gerber, Lynn, Younossi, Zobair M.
Publicado no Medicine (Baltimore) (2018)

Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis

Por Sayiner, Mehmet, Lam, Brian, Golabi, Pegah, Younossi, Zobair M.
Publicado no Therap Adv Gastroenterol (2018)

Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study

Por Younossi, Zobair M, Zheng, Li, Stepanova, Maria, Venkatesan, Chapy, Mishra, Alita
Publicado em 2014

Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population

Por Arshad, Tamoore, Golabi, Pegah, Paik, James, Mishra, Alita, Younossi, Zobair M.
Publicado no Hepatol Commun (2018)

Importance of fatigue and its measurement in chronic liver disease

Por Gerber, Lynn H, Weinstein, Ali A, Mehta, Rohini, Younossi, Zobair M
Publicado no World J Gastroenterol (2019)

Association of Sleep Disorders with Nonalcoholic Fatty Liver Disease (NAFLD): A Population-based Study

Por Mir, Heshaam M., Stepanova, Maria, Afendy, Hena, Cable, Rebecca, Younossi, Zobair M.
Publicado em 2013

The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment

Por Lam, Brian P., Jeffers, Thomas, Younoszai, Zahra, Fazel, Yousef, Younossi, Zobair M.
Publicado no Therap Adv Gastroenterol (2015)

Impact of healthcare reform on the payer mix among young adult emergency department utilizers across the United States (2005–2015)

Por Bush, Haley, Gerber, Lynn H., Stepanova, Maria, Escheik, Carey, Younossi, Zobair M.
Publicado no Medicine (Baltimore) (2018)

The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin

Por Younossi, Zobair M, Birerdinc, Aybike, Estep, Mike, Stepanova, Maria, Afendy, Arian, Baranova, Ancha
Publicado em 2012

Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C)

Por Birerdinc, Aybike, Afendy, Arian, Stepanova, Maria, Younossi, Issah, Baranova, Ancha, Younossi, Zobair M
Publicado em 2012

Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects

Por Mehta, Rohini, Neupane, Arpan, Wang, Lei, Goodman, Zachary, Baranova, Ancha, Younossi, Zobair M
Publicado no BMC Gastroenterol (2014)

Treatment strategies for chronic hepatitis C prior to and following liver transplantation

Por Perumpail, Ryan B, Hahambis, Thomas A, Aggarwal, Avin, Younossi, Zobair M, Ahmed, Aijaz
Publicado no World J Hepatol (2016)